Apricitabine
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Apricitabine, covering 2011-06-23 to 2012-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection [Phase 2, Phase 3]